THE EFFECT OF ADJUVANT CHEMOTHERAPY ON RELAPSE-FREE SURVIVAL IN PATIENTS WITH OSTEOSARCOMA OF THE EXTREMITY

被引：926

作者：

LINK, MP

GOORIN, AM

MISER, AW

GREEN, AA

PRATT, CB

BELASCO, JB

PRITCHARD, J

MALPAS, JS

BAKER, AR

KIRKPATRICK, JA

AYALA, AG

SHUSTER, JJ

ABELSON, HT

SIMONE, JV

VIETTI, TJ

机构：

[1] STANFORD UNIV,MED CTR,STANFORD,CA 94305

[2] CHILDRENS HOSP MED CTR,BOSTON,MA 02115

[3] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115

[4] NCI,PEDIAT ONCOL BRANCH,BETHESDA,MD 20205

[5] NCI,SURG BRANCH,BETHESDA,MD 20205

[6] ST JUDE CHILDRENS RES HOSP,MEMPHIS,TN 38101

[7] ST BARTHOLOMEWS HOSP,LONDON EC1A 7BE,ENGLAND

[8] CHILDRENS HOSP,PHILADELPHIA,PA 19104

[9] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,HOUSTON,TX 77030

[10] PEDIAT ONCOL GRP,STAT OFF,GAINESVILLE,FL

[11] WASHINGTON UNIV,MED CTR,ST LOUIS,MO 63130

来源：

关键词：

D O I：

10.1056/NEJM198606193142502

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1600 / 1606

页数：7

共 31 条

[1] ADJUVANT CHEMOTHERAPY IN OSTEOGENIC-SARCOMA - THE TRIUMPH THAT ISNT
CARTER, SK
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (03) : 147 - 148
[2] CORTES EP, 1978, CANCER TREAT REP, V62, P271
[3] AMPUTATION AND ADRIAMYCIN IN PRIMARY OSTEOSARCOMA
CORTES, EP
HOLLAND, JF
WANG, JJ
SINKS, LF
BLOM, J
SENN, H
BANK, A
GLIDEWELL, O
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (19) : 998 - 1000
[4] CORTES EP, 1979, RECENT RESULTS CANC, V68, P16
[5] OSTEOGENIC SARCOMA - A STUDY OF 6 HUNDRED CASES
DAHLIN, DC
COVENTRY, MB
[J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1967, A 49 (01) : 101 - &
[6] A CONTROLLED PILOT-STUDY OF HIGH-DOSE METHOTREXATE AS POSTSURGICAL ADJUVANT TREATMENT FOR PRIMARY OSTEO-SARCOMA
EDMONSON, JH
GREEN, SJ
IVINS, JC
GILCHRIST, GS
CREAGAN, ET
PRITCHARD, DJ
SMITHSON, WA
DAHLIN, DC
TAYLOR, WF
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (03) : 152 - 156
[7] ETTINGER LJ, 1981, CANCER, V47, P248, DOI 10.1002/1097-0142(19810115)47:2<248::AID-CNCR2820470208>3.0.CO
[8] 2-E
[9] FRIEDMAN M A, 1972, Journal of Surgical Oncology, V4, P482, DOI 10.1002/jso.2930040512
[10] Gehan EA, 1978, IMMUNOTHERAPY CANCER, P271